Immunization
New immunization research from Charite University discussed
Published in Vaccine Weekly, August 26th, 2009
"This study investigated the immunogenicity of Wilms tumor gene product 1 (WT1)-peptide vaccination in WT1-expressing acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients without curative treatment option. Vaccination consisted of granulocyte-macrophage colony-stimulating factor subcutaneously days 1 to 4, and WT1.126-134 peptide and 1 mg keyhole limpet hemocyanin on day 3. The initial 9 patients received 4 vaccinations biweekly, then monthly, and the subsequent 10 patients received continual biweekly vaccination," scientists in Berlin, Germany report.
"Seventeen AML patients and 2 refractory anemia with excess blasts patients received a median of 11...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-08-26)
More Articles from Vaccine Weekly
- Wiley-Blackwell
Studies reveal hepatitis C virus carriers experience substantial increase in mortality - Chagas Disease
Data on Chagas disease described by researchers at University of Alabama - Cyclooxygenase
Research reports from Ohio State University provide new insights into cyclooxygenase - Ebola Hemorrhagic Fever
Investigators at Boston University, Medical Department have published new data on ebola hemorrhagic fever - Epstein-Barr Virus
Research from Rockefeller University broadens understanding of Epstein-Barr virus - Fibrosarcoma
Studies from T. Weiss et al have provided new data on fibrosarcoma - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
